STTK8:00 AMShattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Updateshattucklabs.com
STTK4:05 PMShattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8Results Call • Phase 1Results call Mon, Jun 8, 2026shattucklabs.com
STTK6:15 AMShattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlightsshattucklabs.com